Personalised medicine for cystic fibrosis: treating the basic defect

by J. Stuart Elborn
Published 2013-03-01

Modulator treatment for people with cystic fibrosis: moving in the right direction

by J. Stuart Elborn
Published 2020-03-01

The impact of personalised therapies on respiratory medicine

by J. Stuart Elborn
Published 2013-03-01

Comparison of nasal and bronchial epithelial cells obtained from patients with COPD.

by David M Comer, J Stuart Elborn, Madeleine Ennis
Published 2012-01-01

Personalising airway clearance in chronic lung disease

by Maggie McIlwaine, Judy Bradley, J. Stuart Elborn, Fidelma Moran
Published 2017-02-01

Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.

by Gerard McCaughey, Paul Diamond, J Stuart Elborn, Matt McKevitt, Michael M Tunney
Published 2013-01-01

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His

by Michal Shteinberg, Damian G. Downey, Diane Beattie, John McCaughan, Alastair Reid, Nili Stein, J. Stuart Elborn
Published 2017-03-01

Community analysis and co-occurrence patterns in airway microbial communities during health and disease

by Gisli G. Einarsson, Jiangchao Zhao, John J. LiPuma, Damian G. Downey, Michael M. Tunney, J. Stuart Elborn
Published 2019-07-01

Closed circuit rebreathing to achieve inert gas wash-in for multiple breath wash-out

by Alex R. Horsley, Katherine O'Neill, Damian G. Downey, J. Stuart Elborn, Nicholas J. Bell, Jaclyn Smith, John Owers-Bradley
Published 2016-01-01

Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens

by Deirdre F. Gilpin, Katie-Ann McGown, Kevin Gallagher, Jose Bengoechea, Amy Dumigan, Gisli Einarsson, J. Stuart Elborn, Michael M. Tunney
Published 2019-12-01

New strategies of physical activity assessment in cystic fibrosis: a pilot study

by Daniela Savi, Luigi Graziano, Barbara Giordani, Stefano Schiavetto, Corrado De Vito, Giuseppe Migliara, Nicholas J. Simmonds, Paolo Palange, J. Stuart Elborn
Published 2020-10-01

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.

by Anthony A Fodor, Erich R Klem, Deirdre F Gilpin, J Stuart Elborn, Richard C Boucher, Michael M Tunney, Matthew C Wolfgang
Published 2012-01-01

Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary Applications

by Marcus Hill, Matthew Twigg, Emer A. Sheridan, John G. Hardy, J. Stuart Elborn, Clifford C. Taggart, Christopher J. Scott, Marie E. Migaud
Published 2019-08-01

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.

by Judy M Bradley, Paul Koker, Qiqi Deng, Petra Moroni-Zentgraf, Felix Ratjen, David E Geller, J Stuart Elborn, Tiotropium Cystic Fibrosis Study Group
Published 2014-01-01

Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study.

by Harm A W M Tiddens, Eleni-Rosalina Andrinopoulou, Joe McIntosh, J Stuart Elborn, Eitan Kerem, Nynke Bouma, Jochem Bosch, Mariette Kemner-van de Corput
Published 2020-01-01

Erratum to “Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis”

by T. O. Hirche, C. Knoop, H. Hebestreit, D. Shimmin, A. Solé, J. S. Elborn, H. Ellemunter, P. Aurora, M. Hogardt, T. O. F. Wagner, ECORN-CF Study Group
Published 2015-01-01

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis

by T. O. Hirche, C. Knoop, H. Hebestreit, D. Shimmin, A. Solé, J. S. Elborn, H. Ellemunter, P. Aurora, M. Hogardt, T. O. F. Wagner, ECORN-CF Study Group
Published 2014-01-01

Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult βENaC-Tg Mice

by Ryan Brown, Donna M. Small, Declan F. Doherty, Leslie Holsinger, Robert Booth, Richard Williams, Rebecca J. Ingram, J. Stuart Elborn, Marcus A. Mall, Clifford C. Taggart, Sinéad Weldon
Published 2021-01-01

Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.

by Katherine O'Neill, Judy M Bradley, Elinor Johnston, Stephanie McGrath, Leanne McIlreavey, Stephen Rowan, Alastair Reid, Ian Bradbury, Gisli Einarsson, J Stuart Elborn, Michael M Tunney
Published 2015-01-01

Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo.

by Aaron Scott, Sinéad Weldon, Paul J Buchanan, Bettina Schock, Robert K Ernst, Danny F McAuley, Michael M Tunney, Chris R Irwin, J Stuart Elborn, Clifford C Taggart
Published 2011-01-01